| HCV | Hepatitis C virus |
| DAAs | Direct-acting antivirals |
| HCC | Hepatocellular carcinoma |
| SVR | Sustained virologic response |
| NHL | Non-Hodgkin lymphoma |
| OR | Odds ratio |
| CI | Confidence interval |
| NK | Natural killer |
| HCV | Hepatitis C virus |
| DAAs | Direct-acting antivirals |
| HCC | Hepatocellular carcinoma |
| SVR | Sustained virologic response |
| NHL | Non-Hodgkin lymphoma |
| OR | Odds ratio |
| CI | Confidence interval |
| NK | Natural killer |